EMPOWER: EMesis in Pregnancy - Ondansetron With mEtoclopRamide
key details
| Value | £518,210 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 12 Apr 2017 |
| Contract start | 1 May 2017 |
| Contract end | 31 Mar 2021 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-cbc17c17-d7cf-4aed-9a6a-1f4d0a522cd7 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Modepharma Limited | £518,210 | 11 Apr 2017 | active |
description
Clinical research in to secondary care treatment for severe nausea and vomiting in pregnancy.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 16 Apr 2017 | Award (award) | · | 63c9261c-8e3a-4cae-a292-333165f18cb1-142170 |
more from The Newcastle upon Tyne Hospitals NHS Foundation Trust
- Ways to Wellness · 29 Jul 2026
- Waiting Well · 29 Jul 2026
- Cardiology Insourcing · 23 Jul 2026
- Cellular Pathology · 23 Jul 2026
- Systemic Anti Cancer Therapy · 23 Jul 2026
- Paediatric Diabetes Network Support · 23 Jul 2026
- Laboratory Services Freeman Hospital · 23 Jul 2026
- Lab Services RVI - SQCL · 23 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.